All research
Semaglutide 2026-06-02 PubMed

Oral Semaglutide 25 mg Matches Injectable 2.4 mg for Weight Loss Efficacy in Adults with Obesity

Semaglutide 25 mg Oral Versus Semaglutide 2.4 mg Injectable: An Indirect Treatment Comparison of Weight Loss Outcomes.

Abstract

Oral semaglutide 25 mg and injectable semaglutide 2.4 mg demonstrate comparable weight loss efficacy and safety profiles in adults with obesity, an indirect comparison confirms.


Source: pubmed:42225300 · Ingested 2026-06-02 · Digest: gemini-2.5-flash